Moreover, therapeutic bacteria carrying eukaryotic plasmids encoding cytokines such as IL-4 and IL-18, and angiogenesis inhibitors such as endostatin and thrombospondin all resulted in retardation of tumor growth and prolonged survival of tumor-bearing mice (134, 138–140). This evidence concerns the gene IL4 and neoplasm.